Nearly 25% to 33% of family caregivers across the United States tend to ignore their own needs, resulting in poorer self-care and symptoms of depression and anxiety, according to a research study to be presented at the 2016 Palliative Care in Oncology Symposium.
Nearly 25% to 33% of family caregivers across the United States tend to ignore their own needs, resulting in poorer self-care and symptoms of depression and anxiety, according to a research study to be presented at the 2016 Palliative Care in Oncology Symposium, organized by the American Society of Clinical Oncology (ASCO).
Researchers conducted a cross-sectional survey in community settings of 8 cancer centers located in Alabama, Florida, and Tennessee, which included 294 family caregivers of Medicare beneficiaries. The patients had been diagnosed with high-mortality cancer: pancreatic, lung, brain, ovarian, head and neck, hematologic, or stage IV cancer.
Caregivers perform numerous labor-intensive tasks, including administering medications, providing transportation, assisting with activities of daily life, providing emotional support, coordinating finances, and advocating for healthcare. In the bargain, their ability and inclination to attend to their own needs maybe compromised. Researchers conducting this study assessed participating caregivers using a measures of self-care behavior survey. Caregiver performance on the following was quantified:
“Caregivers and patients are faced with an enormous physical and emotional toll when dealing with advanced cancer,” the study’s lead author J. Nicholas Dionne-Odom, PhD, RN, from the University of Alabama at Birmingham, told ASCO. "When they put their own health and well-being on the back burner, it can affect their care to the patient."
A majority (72.8%) of caregivers who participated in the study were women, with an average age of 66 years, and thus eligible for Medicare, themselves. More than half (54.4%) of these participants had retired, and a majority were white (91.2%). Nearly 54% of caregivers earned less than $50,000 annually, and about 47% of them had a rural dwelling; 60.2% of caregivers were the patient’s spouse or partner.
Nearly three-fourths (71%) of the participating caregivers provided support to the cancer patients for 6 to 7 days each week for more than a year (68%), the authors reported. The intensity of caregiving—meaning longer durations, more number of hours, and more days of care provided each week—was inversely proportional to self-care scores: high-intensity caregiving meant lower self-care. Further, caregiver anxiety, depression, and mental HRQOL scores were lower when they fared worse in self-care domains.
Nearly one-fourth of the respondents reported high levels of depression symptoms and one-third had high levels of anxiety symptoms.
“We hope our research rallies the oncology palliative care communities to develop assessment tools and services that support caregivers,” said Dionne-Odom. “These efforts would help ensure that caregivers are supported and healthy when they take on the important role of caring for an individual with advanced care."
Commenting on these findings, Andrew S. Epstein, MD, from the Memorial Sloan Kettering Cancer Center, said, “More people with cancer are being cared for an in outpatient setting, underscoring that the need for family caregivers to have support is more important than ever. Caregivers are our valuable partners in caring for patients, and this research serves as an important call-to-action for the oncology community to implement support networks and services that care for the caregiver.”
Reference
Dionne-Odom JN, Demark-Wahnefried W, Taylor RA, et al. Differences in self-care behaviors by varying levels of caregiving intensity, performance, and well-being among family caregivers of patients with high-mortality cancer. J Clin Oncol. 2016;34(suppl 26S; abstract 239).
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More